{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:13:34Z","timestamp":1788552814566,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T00:00:00Z","timestamp":1434499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12881-015-0185-y","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T01:35:03Z","timestamp":1434418503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated"],"prefix":"10.1186","volume":"16","author":[{"given":"Cristina","family":"Cabrera-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Bullich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Bissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Ars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,17]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"CG Iglesias","year":"1983","unstructured":"Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980. Am J Kidney Dis. 1983;2:630\u20139.","journal-title":"Am J Kidney Dis"},{"key":"185_CR2","first-page":"1","volume":"328","author":"OZ Dalgaard","year":"1957","unstructured":"Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957;328:1\u2013255.","journal-title":"Acta Med Scand Suppl"},{"key":"185_CR3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.10.007","author":"AJ Collins","year":"2011","unstructured":"Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011. doi:10.1053\/j.ajkd.2010.10.007.","journal-title":"Am J Kidney Dis"},{"key":"185_CR4","unstructured":"Catalan Transplant Organisation HD GdC. Catalan Renal Registry. 2011."},{"key":"185_CR5","doi-asserted-by":"crossref","unstructured":"The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;78.","DOI":"10.1016\/0092-8674(94)90137-6"},{"key":"185_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","volume":"272","author":"T Mochizuki","year":"1996","unstructured":"Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272:1339\u201342.","journal-title":"Science"},{"key":"185_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991. doi:10.1111\/j.1749-6632.1991.tb37754.x.","journal-title":"Ann N Y Acad Sci"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243\u201354.","journal-title":"Pediatr Neurol"},{"key":"185_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra055323","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006. doi:10.1056\/NEJMra055323.","journal-title":"N Engl J Med"},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2013a contiguous gene syndrome. Nat Genet. 1994;8:328\u201332.","journal-title":"Nat Genet"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/ajkd.1998.v31.pm9631851","volume":"31","author":"R Torra","year":"1998","unstructured":"Torra R, Badenas C, Darnell A, Camacho JA, Aspinwall R, Harris PC, et al. Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies. Am J Kidney Dis. 1998;31:1038\u201343.","journal-title":"Am J Kidney Dis"},{"key":"185_CR12","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ki.2008.485","volume":"74","author":"MB Consugar","year":"2008","unstructured":"Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, et al. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome. Kidney Int. 2008;74:1468\u201379.","journal-title":"Kidney Int"},{"key":"185_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/jmg.40.2.e17","volume":"40","author":"YM Smulders","year":"2003","unstructured":"Smulders YM, Eussen BH, Verhoef SWC. Large deletion causing the TSC2-PKD1 contiguous gene syndrome without infantil polycytic disease. J Med Genet. 2003;40:2\u20134.","journal-title":"J Med Genet"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00000478-200202000-00006","volume":"26","author":"G Martignoni","year":"2002","unstructured":"Martignoni G, Bonetti F, Pea M, Tardanico R, Brunelli M, Eble JN. Renal disease in adults with TSC2\/PKD1 contiguous gene syndrome. Am J Surg Pathol. 2002;26:198\u2013205.","journal-title":"Am J Surg Pathol"},{"key":"185_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000059874","volume":"122","author":"C Mancino","year":"1997","unstructured":"Mancino C, Balducci A. Tuberous sclerosis complex and early-onset autosomal dominant polycystic kidney disease as a \u201ccontiguous gene\u201d syndrome: report of a case. Contrib Nephrol. 1997;122:96\u20137.","journal-title":"Contrib Nephrol"},{"key":"185_CR16","first-page":"351","volume":"58","author":"T Culty","year":"2006","unstructured":"Culty T, Molinie V, Lebret T, Savareux L, Souid M, Delahousse M, et al. TSC2\/PKD1 contiguous gene syndrome in an adult. Minerva Urol Nefrol. 2006;58:351\u20134.","journal-title":"Minerva Urol Nefrol"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1086\/514888","volume":"61","author":"JR Sampson","year":"1997","unstructured":"Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D, et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet. 1997;61:843\u201351.","journal-title":"Am J Hum Genet"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589\u201394.","journal-title":"J Cell Sci"},{"key":"185_CR19","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/MCB.01259-08","volume":"29","author":"G Distefano","year":"2009","unstructured":"Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, et al. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol Cell Biol. 2009;29:2359\u201371.","journal-title":"Mol Cell Biol"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.4161\/cc.5.21.3408","volume":"5","author":"T Weimbs","year":"2006","unstructured":"Weimbs T. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? Cell Cycle. 2006;5:2425\u20139.","journal-title":"Cell Cycle"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","volume":"5","author":"R Dere","year":"2010","unstructured":"Dere R, Wilson PD, Sandford RN, Walker CL. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One. 2010;5:e9239.","journal-title":"PLoS One"},{"key":"185_CR22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063564","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008. doi:10.1056\/NEJMoa063564.","journal-title":"N Engl J Med"},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381:817\u201324.","journal-title":"Lancet"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res. 2011;17:4071\u201381.","journal-title":"Clin Cancer Res"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1750-1172-7-87","volume":"7","author":"C Cabrera-Lopez","year":"2012","unstructured":"Cabrera-Lopez C, Marti T, Catala V, Torres F, Mateu S, Ballarin J, et al. Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial. Orphanet J Rare Dis. 2012;7:87.","journal-title":"Orphanet J Rare Dis"},{"key":"185_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023379","volume":"6","author":"SL Dabora","year":"2011","unstructured":"Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario Jr FJ, Miles D, et al. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress VEGF-D levels descrease. PLoS One. 2011;6, e23379.","journal-title":"PLoS One"},{"key":"185_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363:820\u20139.","journal-title":"N Engl J Med"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa M, Nurnberger J, Wanner C, Sommerer C, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363:830\u201340.","journal-title":"N Engl J Med"},{"key":"185_CR29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00185.x","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int. 2003. doi:10.1046\/j.1523-1755.2003.00185.x.","journal-title":"Kidney Int"},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","volume":"24","author":"KT Bae","year":"2000","unstructured":"Bae KT, Commean PK, Lee J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr. 2000;24:614\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"185_CR31","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1046\/j.1523-1755.2002.00326.x","volume":"61","author":"S Rossetti","year":"2002","unstructured":"Rossetti S, Chauveau D, Walker D, Saggar-Malik A, Winearls CG, Torres VE, et al. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int. 2002;61:1588\u201399.","journal-title":"Kidney Int"},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3\u2014new capabilities and interfaces. Nucleic Acids Res. 2012;40:e115.","journal-title":"Nucleic Acids Res"},{"key":"185_CR33","first-page":"E1","volume":"57","author":"Y Oyazato","year":"2011","unstructured":"Oyazato Y, Iijima K, Emi M, Sekine T, Kamei K, Takanashi J, et al. Molecular analysis of TSC2\/PKD1 contiguous gene deletion syndrome. Kobe J Med Sci. 2011;57:E1\u201310.","journal-title":"Kobe J Med Sci"},{"key":"185_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000059909","volume":"122","author":"L Longa","year":"1997","unstructured":"Longa L, Brusco A, Carbonara C, Polidoro S, Scolari F, Valzorio B, et al. A tuberous sclerosis patient with a large TSC2 and PKD1 gene deletion shows extrarenal signs of autosomal dominant polycystic kidney disease. Contrib Nephrol. 1997;122:91\u20135.","journal-title":"Contrib Nephrol"},{"key":"185_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201625","author":"JRW Yates","year":"2006","unstructured":"Yates JRW. Tuberous sclerosis. Eur J Hum Genet. 2006. doi:10.1038\/sj.ejhg.5201625.","journal-title":"Eur J Hum Genet"},{"key":"185_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet. 2005;13:731\u201341.","journal-title":"Eur J Hum Genet"},{"key":"185_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0308-9","author":"P Kozlowski","year":"2007","unstructured":"Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, Northrup H, et al. Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet. 2007. doi:10.1007\/s00439-006-0308-9.","journal-title":"Hum Genet"},{"key":"185_CR38","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2006.10.024","volume":"49","author":"D Boehm","year":"2007","unstructured":"Boehm D, Bacher J, Neumann HP. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay. Am J Kidney Dis. 2007;49:e11\u201321.","journal-title":"Am J Kidney Dis"},{"key":"185_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.gim.0000204466.34876.d5","volume":"8","author":"AC Woerner","year":"2006","unstructured":"Woerner AC, Au KS, Williams AT, Harris PCNH. Tuberous sclerosis complex and polycystic kidney disease together: an exception to the contiguous gene syndrome. Genet Med. 2006;8:197\u20138.","journal-title":"Genet Med"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/hmg\/ddn325","volume":"18","author":"TR Hartman","year":"2009","unstructured":"Hartman TR, Liu D, Zilfou JT, Robb V, Morrison T, Watnick T, et al. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet. 2009;18:151\u201363.","journal-title":"Hum Mol Genet"},{"key":"185_CR41","doi-asserted-by":"publisher","first-page":"F541","DOI":"10.1152\/ajprenal.00273.2001","volume":"282","author":"BK Yoder","year":"2002","unstructured":"Yoder BK, Tousson A, Millican L, Wu JH, Bugg Jr CE, Schafer JA, et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am J Physiol Ren Physiol. 2002;282:F541\u201352.","journal-title":"Am J Physiol Ren Physiol"},{"key":"185_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ndt\/gfq617","volume":"26","author":"E Schonenberger","year":"2011","unstructured":"Schonenberger E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant. 2011;26:18\u201324.","journal-title":"Nephrol Dial Transplant"},{"key":"185_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1681\/ASN.2011070690","volume":"23","author":"DP Cina","year":"2012","unstructured":"Cina DP, Onay T, Paltoo A, Li C, Maezawa Y, De Arteaga J, et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol. 2012;23:412\u201320.","journal-title":"J Am Soc Nephrol"},{"key":"185_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.trre.2007.12.001","volume":"22","author":"E Letavernier","year":"2008","unstructured":"Letavernier E, Legendre C. mToR inhibitors-induced proteinuria: mechanisms, significance, and management. Transplant Rev. 2008;22:125\u201330.","journal-title":"Transplant Rev"},{"key":"185_CR45","doi-asserted-by":"publisher","first-page":"F569","DOI":"10.1152\/ajprenal.00180.2012","volume":"303","author":"AH Kirsch","year":"2012","unstructured":"Kirsch AH, Riegelbauer V, Tagwerker A, Rudnicki M, Rosenkranz AR, Eller K. The mTOR-inhibitor rapamycin mediates proteinuria in nephrotoxic serum nephritis by activating the innate immune response. Am J Physiol Renal Physiol. 2012;303:F569\u201375.","journal-title":"Am J Physiol Renal Physiol"},{"key":"185_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.trre.2011.10.003","volume":"26","author":"F Diekmann","year":"2012","unstructured":"Diekmann F, Andres A, Oppenheimer F. mTOR inhibitor-associated proteinuria in kidney transplant recipients. Transplant Rev. 2012;26:27\u20139.","journal-title":"Transplant Rev"},{"key":"185_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/TP.0b013e318211d342","volume":"91","author":"G Stallone","year":"2011","unstructured":"Stallone G, Infante B, Pontrelli P, Gigante M, Montemurno E, Loverre A, et al. Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins. Transplantation. 2011;91:997\u20131004.","journal-title":"Transplantation"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-015-0185-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0185-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T16:31:34Z","timestamp":1630600294000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-015-0185-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s12881-015-0185-y","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,17]]},"assertion":[{"value":"27 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}